GO Annotation
| Category | Term ID | Term description |
|---|---|---|
| Process | GO:0001508 | Action potential |
| Process | GO:0001654 | Eye development |
| Process | GO:0002027 | Regulation of heart rate |
| Process | GO:0002376 | Immune system process |
| Process | GO:0002520 | Immune system development |
| Process | GO:0002790 | Peptide secretion |
| Process | GO:0003008 | System process |
| Process | GO:0003012 | Muscle system process |
| Process | GO:0003013 | Circulatory system process |
| Process | GO:0003014 | Renal system process |
| Process | GO:0003015 | Heart process |
| Process | GO:0003018 | Vascular process in circulatory system |
| Process | GO:0006810 | Transport |
| Process | GO:0006811 | Ion transport |
| Process | GO:0006812 | Cation transport |
| Process | GO:0006816 | Calcium ion transport |
| Process | GO:0006873 | Cellular ion homeostasis |
| Process | GO:0006874 | Cellular calcium ion homeostasis |
| Process | GO:0006875 | Cellular metal ion homeostasis |
| Process | GO:0006887 | Exocytosis |
| Process | GO:0006936 | Muscle contraction |
| Process | GO:0006937 | Regulation of muscle contraction |
| Process | GO:0006939 | Smooth muscle contraction |
| Process | GO:0006941 | Striated muscle contraction |
| Process | GO:0006942 | Regulation of striated muscle contraction |
| Process | GO:0007154 | Cell communication |
| Process | GO:0007165 | Signal transduction |
| Process | GO:0007204 | Positive regulation of cytosolic calcium ion concentration |
| Process | GO:0007267 | Cell-cell signaling |
| Process | GO:0007268 | Chemical synaptic transmission |
| Process | GO:0007275 | Multicellular organism development |
| Process | GO:0007423 | Sensory organ development |
| Process | GO:0007507 | Heart development |
| Process | GO:0007588 | Excretion |
| Process | GO:0007610 | Behavior |
| Process | GO:0007611 | Learning or memory |
| Process | GO:0007612 | Learning |
| Process | GO:0007626 | Locomotory behavior |
| Process | GO:0007628 | Adult walking behavior |
| Process | GO:0007632 | Visual behavior |
| Process | GO:0008015 | Blood circulation |
| Process | GO:0008016 | Regulation of heart contraction |
| Process | GO:0008104 | Protein localization |
| Process | GO:0008217 | Regulation of blood pressure |
| Process | GO:0008306 | Associative learning |
| Process | GO:0008344 | Adult locomotory behavior |
| Process | GO:0008542 | Visual learning |
| Process | GO:0009306 | Protein secretion |
| Process | GO:0009314 | Response to radiation |
| Process | GO:0009416 | Response to light stimulus |
| Process | GO:0009628 | Response to abiotic stimulus |
| Process | GO:0009653 | Anatomical structure morphogenesis |
| Process | GO:0009719 | Response to endogenous stimulus |
| Process | GO:0009790 | Embryo development |
| Process | GO:0009914 | Hormone transport |
| Process | GO:0009987 | Cellular process |
| Process | GO:0010033 | Response to organic substance |
| Process | GO:0010243 | Response to organonitrogen compound |
| Process | GO:0010817 | Regulation of hormone levels |
| Process | GO:0010880 | Regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum |
| Process | GO:0010881 | Regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion |
| Process | GO:0010882 | Regulation of cardiac muscle contraction by calcium ion signaling |
| Process | GO:0010959 | Regulation of metal ion transport |
| Process | GO:0014832 | Urinary bladder smooth muscle contraction |
| Process | GO:0014848 | Urinary tract smooth muscle contraction |
| Process | GO:0015031 | Protein transport |
| Process | GO:0015833 | Peptide transport |
| Process | GO:0016192 | Vesicle-mediated transport |
| Process | GO:0017156 | Calcium-ion regulated exocytosis |
| Process | GO:0019229 | Regulation of vasoconstriction |
| Process | GO:0019722 | Calcium-mediated signaling |
| Process | GO:0019725 | Cellular homeostasis |
| Process | GO:0019932 | Second-messenger-mediated signaling |
| Process | GO:0023052 | Signaling |
| Process | GO:0023061 | Signal release |
| Process | GO:0030001 | Metal ion transport |
| Process | GO:0030003 | Cellular cation homeostasis |
| Process | GO:0030029 | Actin filament-based process |
| Process | GO:0030048 | Actin filament-based movement |
| Process | GO:0030072 | Peptide hormone secretion |
| Process | GO:0030073 | Insulin secretion |
| Process | GO:0030252 | Growth hormone secretion |
| Process | GO:0030326 | Embryonic limb morphogenesis |
| Process | GO:0030534 | Adult behavior |
| Process | GO:0031279 | Regulation of cyclase activity |
| Process | GO:0031281 | Positive regulation of cyclase activity |
| Process | GO:0032501 | Multicellular organismal process |
| Process | GO:0032502 | Developmental process |
| Process | GO:0032879 | Regulation of localization |
| Process | GO:0032940 | Secretion by cell |
| Process | GO:0032970 | Regulation of actin filament-based process |
| Process | GO:0033036 | Macromolecule localization |
| Process | GO:0033500 | Carbohydrate homeostasis |
| Process | GO:0034220 | Ion transmembrane transport |
| Process | GO:0034762 | Regulation of transmembrane transport |
| Process | GO:0034764 | Positive regulation of transmembrane transport |
| Process | GO:0034765 | Regulation of ion transmembrane transport |
| Process | GO:0034767 | Positive regulation of ion transmembrane transport |
| Process | GO:0035107 | Appendage morphogenesis |
| Process | GO:0035108 | Limb morphogenesis |
| Process | GO:0035113 | Embryonic appendage morphogenesis |
| Process | GO:0035115 | Embryonic forelimb morphogenesis |
| Process | GO:0035136 | Forelimb morphogenesis |
| Process | GO:0035150 | Regulation of tube size |
| Process | GO:0035296 | Regulation of tube diameter |
| Process | GO:0035556 | Intracellular signal transduction |
| Process | GO:0035592 | Establishment of protein localization to extracellular region |
| Process | GO:0035637 | Multicellular organismal signaling |
| Process | GO:0040008 | Regulation of growth |
| Process | GO:0042221 | Response to chemical |
| Process | GO:0042391 | Regulation of membrane potential |
| Process | GO:0042592 | Homeostatic process |
| Process | GO:0042593 | Glucose homeostasis |
| Process | GO:0042886 | Amide transport |
| Process | GO:0043010 | Camera-type eye development |
| Process | GO:0043085 | Positive regulation of catalytic activity |
| Process | GO:0043269 | Regulation of ion transport |
| Process | GO:0043270 | Positive regulation of ion transport |
| Process | GO:0044057 | Regulation of system process |
| Process | GO:0044093 | Positive regulation of molecular function |
| Process | GO:0045055 | Regulated exocytosis |
| Process | GO:0045184 | Establishment of protein localization |
| Process | GO:0045761 | Regulation of adenylate cyclase activity |
| Process | GO:0045762 | Positive regulation of adenylate cyclase activity |
| Process | GO:0046620 | Regulation of organ growth |
| Process | GO:0046879 | Hormone secretion |
| Process | GO:0046903 | Secretion |
| Process | GO:0048513 | Animal organ development |
| Process | GO:0048518 | Positive regulation of biological process |
| Process | GO:0048522 | Positive regulation of cellular process |
| Process | GO:0048598 | Embryonic morphogenesis |
| Process | GO:0048638 | Regulation of developmental growth |
| Process | GO:0048731 | System development |
| Process | GO:0048736 | Appendage development |
| Process | GO:0048856 | Anatomical structure development |
| Process | GO:0048878 | Chemical homeostasis |
| Process | GO:0048880 | Sensory system development |
| Process | GO:0050789 | Regulation of biological process |
| Process | GO:0050790 | Regulation of catalytic activity |
| Process | GO:0050793 | Regulation of developmental process |
| Process | GO:0050794 | Regulation of cellular process |
| Process | GO:0050801 | Ion homeostasis |
| Process | GO:0050877 | Nervous system process |
| Process | GO:0050890 | Cognition |
| Process | GO:0050896 | Response to stimulus |
| Process | GO:0051049 | Regulation of transport |
| Process | GO:0051050 | Positive regulation of transport |
| Process | GO:0051179 | Localization |
| Process | GO:0051234 | Establishment of localization |
| Process | GO:0051239 | Regulation of multicellular organismal process |
| Process | GO:0051279 | Regulation of release of sequestered calcium ion into cytosol |
| Process | GO:0051282 | Regulation of sequestering of calcium ion |
| Process | GO:0051339 | Regulation of lyase activity |
| Process | GO:0051349 | Positive regulation of lyase activity |
| Process | GO:0051641 | Cellular localization |
| Process | GO:0051716 | Cellular response to stimulus |
| Process | GO:0051899 | Membrane depolarization |
| Process | GO:0051924 | Regulation of calcium ion transport |
| Process | GO:0051928 | Positive regulation of calcium ion transport |
| Process | GO:0055065 | Metal ion homeostasis |
| Process | GO:0055074 | Calcium ion homeostasis |
| Process | GO:0055080 | Cation homeostasis |
| Process | GO:0055082 | Cellular chemical homeostasis |
| Process | GO:0055085 | Transmembrane transport |
| Process | GO:0055117 | Regulation of cardiac muscle contraction |
| Process | GO:0060047 | Heart contraction |
| Process | GO:0060048 | Cardiac muscle contraction |
| Process | GO:0060073 | Micturition |
| Process | GO:0060078 | Regulation of postsynaptic membrane potential |
| Process | GO:0060083 | Smooth muscle contraction involved in micturition |
| Process | GO:0060173 | Limb development |
| Process | GO:0060402 | Calcium ion transport into cytosol |
| Process | GO:0061337 | Cardiac conduction |
| Process | GO:0061577 | Calcium ion transmembrane transport via high voltage-gated calcium channel |
| Process | GO:0065007 | Biological regulation |
| Process | GO:0065008 | Regulation of biological quality |
| Process | GO:0065009 | Regulation of molecular function |
| Process | GO:0070252 | Actin-mediated cell contraction |
| Process | GO:0070509 | Calcium ion import |
| Process | GO:0070588 | Calcium ion transmembrane transport |
| Process | GO:0070727 | Cellular macromolecule localization |
| Process | GO:0070887 | Cellular response to chemical stimulus |
| Process | GO:0071310 | Cellular response to organic substance |
| Process | GO:0071417 | Cellular response to organonitrogen compound |
| Process | GO:0071495 | Cellular response to endogenous stimulus |
| Process | GO:0071692 | Protein localization to extracellular region |
| Process | GO:0071702 | Organic substance transport |
| Process | GO:0071705 | Nitrogen compound transport |
| Process | GO:0072359 | Circulatory system development |
| Process | GO:0072503 | Cellular divalent inorganic cation homeostasis |
| Process | GO:0072507 | Divalent inorganic cation homeostasis |
| Process | GO:0086001 | Cardiac muscle cell action potential |
| Process | GO:0086002 | Cardiac muscle cell action potential involved in contraction |
| Process | GO:0086003 | Cardiac muscle cell contraction |
| Process | GO:0086004 | Regulation of cardiac muscle cell contraction |
| Process | GO:0086010 | Membrane depolarization during action potential |
| Process | GO:0086012 | Membrane depolarization during cardiac muscle cell action potential |
| Process | GO:0086014 | Atrial cardiac muscle cell action potential |
| Process | GO:0086016 | AV node cell action potential |
| Process | GO:0086019 | Cell-cell signaling involved in cardiac conduction |
| Process | GO:0086026 | Atrial cardiac muscle cell to AV node cell signaling |
| Process | GO:0086027 | AV node cell to bundle of His cell signaling |
| Process | GO:0086045 | Membrane depolarization during AV node cell action potential |
| Process | GO:0086065 | Cell communication involved in cardiac conduction |
| Process | GO:0086066 | Atrial cardiac muscle cell to AV node cell communication |
| Process | GO:0086067 | AV node cell to bundle of His cell communication |
| Process | GO:0086091 | Regulation of heart rate by cardiac conduction |
| Process | GO:0090066 | Regulation of anatomical structure size |
| Process | GO:0090257 | Regulation of muscle system process |
| Process | GO:0090659 | Walking behavior |
| Process | GO:0097553 | Calcium ion transmembrane import into cytosol |
| Process | GO:0097746 | Blood vessel diameter maintenance |
| Process | GO:0098655 | Cation transmembrane transport |
| Process | GO:0098657 | Import into cell |
| Process | GO:0098659 | Inorganic cation import across plasma membrane |
| Process | GO:0098660 | Inorganic ion transmembrane transport |
| Process | GO:0098662 | Inorganic cation transmembrane transport |
| Process | GO:0098703 | Calcium ion import across plasma membrane |
| Process | GO:0098739 | Import across plasma membrane |
| Process | GO:0098771 | Inorganic ion homeostasis |
| Process | GO:0098900 | Regulation of action potential |
| Process | GO:0098901 | Regulation of cardiac muscle cell action potential |
| Process | GO:0098911 | Regulation of ventricular cardiac muscle cell action potential |
| Process | GO:0098912 | Membrane depolarization during atrial cardiac muscle cell action potential |
| Process | GO:0098916 | Anterograde trans-synaptic signaling |
| Process | GO:0099536 | Synaptic signaling |
| Process | GO:0099537 | Trans-synaptic signaling |
| Process | GO:0099587 | Inorganic ion import across plasma membrane |
| Process | GO:0140352 | Export from cell |
| Process | GO:0150063 | Visual system development |
| Process | GO:1901652 | Response to peptide |
| Process | GO:1901653 | Cellular response to peptide |
| Process | GO:1901698 | Response to nitrogen compound |
| Process | GO:1901699 | Cellular response to nitrogen compound |
| Process | GO:1901700 | Response to oxygen-containing compound |
| Process | GO:1901701 | Cellular response to oxygen-containing compound |
| Process | GO:1902514 | Regulation of calcium ion transmembrane transport via high voltage-gated calcium channel |
| Process | GO:1903115 | Regulation of actin filament-based movement |
| Process | GO:1903169 | Regulation of calcium ion transmembrane transport |
| Process | GO:1903522 | Regulation of blood circulation |
| Process | GO:1904062 | Regulation of cation transmembrane transport |
| Process | GO:1904064 | Positive regulation of cation transmembrane transport |
| Process | GO:1904427 | Positive regulation of calcium ion transmembrane transport |
| Process | GO:1904645 | Response to amyloid-beta |
| Process | GO:1904646 | Cellular response to amyloid-beta |
| Process | GO:1904879 | Positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel |
| Component | GO:0002095 | Caveolar macromolecular signaling complex |
| Component | GO:0005622 | Intracellular anatomical structure |
| Component | GO:0005737 | Cytoplasm |
| Component | GO:0005886 | Plasma membrane |
| Component | GO:0005887 | Integral component of plasma membrane |
| Component | GO:0005891 | Voltage-gated calcium channel complex |
| Component | GO:0005901 | Caveola |
| Component | GO:0009986 | Cell surface |
| Component | GO:0014069 | Postsynaptic density |
| Component | GO:0016020 | Membrane |
| Component | GO:0016021 | Integral component of membrane |
| Component | GO:0030016 | Myofibril |
| Component | GO:0030017 | Sarcomere |
| Component | GO:0030018 | Z disc |
| Component | GO:0030054 | Cell junction |
| Component | GO:0030315 | T-tubule |
| Component | GO:0030425 | Dendrite |
| Component | GO:0031224 | Intrinsic component of membrane |
| Component | GO:0031226 | Intrinsic component of plasma membrane |
| Component | GO:0031674 | I band |
| Component | GO:0032279 | Asymmetric synapse |
| Component | GO:0032991 | Protein-containing complex |
| Component | GO:0034702 | Ion channel complex |
| Component | GO:0034703 | Cation channel complex |
| Component | GO:0034704 | Calcium channel complex |
| Component | GO:0036477 | Somatodendritic compartment |
| Component | GO:0042383 | Sarcolemma |
| Component | GO:0042734 | Presynaptic membrane |
| Component | GO:0042995 | Cell projection |
| Component | GO:0043005 | Neuron projection |
| Component | GO:0043025 | Neuronal cell body |
| Component | GO:0043198 | Dendritic shaft |
| Component | GO:0043204 | Perikaryon |
| Component | GO:0043226 | Organelle |
| Component | GO:0043228 | Non-membrane-bounded organelle |
| Component | GO:0043229 | Intracellular organelle |
| Component | GO:0043232 | Intracellular non-membrane-bounded organelle |
| Component | GO:0043292 | Contractile fiber |
| Component | GO:0044297 | Cell body |
| Component | GO:0044853 | Plasma membrane raft |
| Component | GO:0045121 | Membrane raft |
| Component | GO:0045202 | Synapse |
| Component | GO:0045211 | Postsynaptic membrane |
| Component | GO:0070161 | Anchoring junction |
| Component | GO:0071944 | Cell periphery |
| Component | GO:0097060 | Synaptic membrane |
| Component | GO:0097447 | Dendritic tree |
| Component | GO:0098590 | Plasma membrane region |
| Component | GO:0098793 | Presynapse |
| Component | GO:0098794 | Postsynapse |
| Component | GO:0098796 | Membrane protein complex |
| Component | GO:0098797 | Plasma membrane protein complex |
| Component | GO:0098839 | Postsynaptic density membrane |
| Component | GO:0098857 | Membrane microdomain |
| Component | GO:0098889 | Intrinsic component of presynaptic membrane |
| Component | GO:0098936 | Intrinsic component of postsynaptic membrane |
| Component | GO:0098978 | Glutamatergic synapse |
| Component | GO:0098984 | Neuron to neuron synapse |
| Component | GO:0099055 | Integral component of postsynaptic membrane |
| Component | GO:0099056 | Integral component of presynaptic membrane |
| Component | GO:0099080 | Supramolecular complex |
| Component | GO:0099081 | Supramolecular polymer |
| Component | GO:0099240 | Intrinsic component of synaptic membrane |
| Component | GO:0099512 | Supramolecular fiber |
| Component | GO:0099572 | Postsynaptic specialization |
| Component | GO:0099634 | Postsynaptic specialization membrane |
| Component | GO:0099699 | Integral component of synaptic membrane |
| Component | GO:0110165 | Cellular anatomical entity |
| Component | GO:0120025 | Plasma membrane bounded cell projection |
| Component | GO:1902495 | Transmembrane transporter complex |
| Component | GO:1990351 | Transporter complex |
| Component | GO:1990454 | L-type voltage-gated calcium channel complex |
| Function | GO:0005215 | Transporter activity |
| Function | GO:0005216 | Ion channel activity |
| Function | GO:0005244 | Voltage-gated ion channel activity |
| Function | GO:0005245 | Voltage-gated calcium channel activity |
| Function | GO:0005261 | Cation channel activity |
| Function | GO:0005262 | Calcium channel activity |
| Function | GO:0005488 | Binding |
| Function | GO:0005515 | Protein binding |
| Function | GO:0005516 | Calmodulin binding |
| Function | GO:0008092 | Cytoskeletal protein binding |
| Function | GO:0008324 | Cation transmembrane transporter activity |
| Function | GO:0008331 | High voltage-gated calcium channel activity |
| Function | GO:0015075 | Ion transmembrane transporter activity |
| Function | GO:0015085 | Calcium ion transmembrane transporter activity |
| Function | GO:0015267 | Channel activity |
| Function | GO:0015318 | Inorganic molecular entity transmembrane transporter activity |
| Function | GO:0019899 | Enzyme binding |
| Function | GO:0019902 | Phosphatase binding |
| Function | GO:0019903 | Protein phosphatase binding |
| Function | GO:0019904 | Protein domain specific binding |
| Function | GO:0022803 | Passive transmembrane transporter activity |
| Function | GO:0022832 | Voltage-gated channel activity |
| Function | GO:0022836 | Gated channel activity |
| Function | GO:0022843 | Voltage-gated cation channel activity |
| Function | GO:0022857 | Transmembrane transporter activity |
| Function | GO:0022890 | Inorganic cation transmembrane transporter activity |
| Function | GO:0031369 | Translation initiation factor binding |
| Function | GO:0042805 | Actinin binding |
| Function | GO:0043167 | Ion binding |
| Function | GO:0043169 | Cation binding |
| Function | GO:0044325 | Transmembrane transporter binding |
| Function | GO:0046872 | Metal ion binding |
| Function | GO:0046873 | Metal ion transmembrane transporter activity |
| Function | GO:0051393 | Alpha-actinin binding |
| Function | GO:0051721 | Protein phosphatase 2A binding |
| Function | GO:0086007 | Voltage-gated calcium channel activity involved in cardiac muscle cell action potential |
| Function | GO:0086056 | Voltage-gated calcium channel activity involved in AV node cell action potential |
| Function | GO:1905030 | Voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential |
Pathway annotation
Expression profile of Cacna1c in omics data
| ID | GSE100499 |
| Title | Exploring acupuncture mechanism in preconditioning of IRI |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM2685201 | MX1 | tissue: Myocardium gender: male | 9.57422935 |
| GSM2685202 | MX2 | tissue: Myocardium gender: female | 9.4856932 |
| GSM2685203 | MX3 | tissue: Myocardium gender: female | 9.9963627 |
| GSM2685204 | MX4 | tissue: Myocardium gender: male | 9.72627085 |
| GSM2685205 | DZ1 | tissue: Myocardium gender: male | 9.84500585 |
| GSM2685206 | DZ2 | tissue: Myocardium gender: male | 9.5875 |
| GSM2685207 | DZ3 | tissue: Myocardium gender: female | 9.739869200000001 |
| GSM2685208 | DZ4 | tissue: Myocardium gender: female | 9.657130350000001 |
| GSM2685209 | JJ1 | tissue: Myocardium gender: male | 9.55933385 |
| GSM2685210 | JJ2 | tissue: Myocardium gender: female | 9.533069000000001 |
| GSM2685211 | JJ3 | tissue: Myocardium gender: female | 9.70592675 |
| GSM2685212 | JJ4 | tissue: Myocardium gender: male | 9.7751098 |
| GSM2685213 | NG1 | tissue: Myocardium gender: male | 9.954476750000001 |
| GSM2685214 | NG2 | tissue: Myocardium gender: female | 9.83881375 |
| GSM2685215 | NG3 | tissue: Myocardium gender: male | 9.6817386 |
| GSM2685216 | NG4 | tissue: Myocardium gender: female | 9.840812 |
| GSM2685217 | YL1 | tissue: Myocardium gender: male | 9.560106 |
| GSM2685218 | YL2 | tissue: Myocardium gender: male | 9.51680675 |
| GSM2685219 | YL3 | tissue: Myocardium gender: female | 9.65240475 |
| GSM2685220 | YL4 | tissue: Myocardium gender: female | 9.5148702 |
| GSM2685221 | QC1 | tissue: Myocardium gender: male | 9.6612558 |
| GSM2685222 | QC2 | tissue: Myocardium gender: male | 9.37014275 |
| GSM2685223 | QC3 | tissue: Myocardium gender: female | 9.408677749999999 |
| GSM2685224 | QC4 | tissue: Myocardium gender: female | 9.7666955 |
| ID | GSE136833 |
| Title | Effects of lidocaine on the expression of rat spinal cord |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4058984 | Control_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.565825044 |
| GSM4058985 | Control_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.783508249 |
| GSM4058986 | Control_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.691094557 |
| GSM4058987 | Lidocaine_1 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.785007287 |
| GSM4058988 | Lidocaine_2 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.56302524 |
| GSM4058989 | Lidocaine_3 | strain: Sprague-Dawley tissue: Lumbar segment of spinal cord | 5.659865601 |
| ID | GSE138454 |
| Title | Impact of inflammation on hepatic subcellular energetics in anesthetized rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4108997 | Sample 1 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 4.0 |
| GSM4108998 | Sample 2 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 9.0 |
| GSM4108999 | Sample 3 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 10.0 |
| GSM4109000 | Sample 4 Isoflurane sepsis | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 6.0 |
| GSM4109001 | Sample 5 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 11.0 |
| GSM4109002 | Sample 6 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 11.0 |
| GSM4109003 | Sample 7 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 11.0 |
| GSM4109004 | Sample 8 Isoflurane control | anesthetic background: Isoflurane strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 14.0 |
| GSM4109005 | Sample9 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 7.0 |
| GSM4109006 | Sample10 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 24.0 |
| GSM4109007 | Sample11 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 10.0 |
| GSM4109008 | Sample12 Propofol sepsis | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: sepsis gender: male | 12.0 |
| GSM4109009 | Sample13 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 5.0 |
| GSM4109010 | Sample14 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 12.0 |
| GSM4109011 | Sample 15 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 4.0 |
| GSM4109012 | Sample16 Propofol control | anesthetic background: Propofol strain: Sprague-Dawley age: 10 weeks old sepsis/control: control gender: male | 12.0 |
| ID | GSE139220 |
| Title | Expression data from sevoflurane anesthesia treated rat |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4134285 | Brain_Control_rep1 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 8.357677 |
| GSM4134286 | Brain_Control_rep2 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 8.197407 |
| GSM4134287 | Brain_Control_rep3 | strain: Sprague-Dawley age: 18-month old treatment: control tissue: hippocampus | 8.122421 |
| GSM4134288 | Brain_Sevoflurane_rep1 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 8.124162 |
| GSM4134289 | Brain_Sevoflurane_rep2 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 8.371035 |
| GSM4134290 | Brain_Sevoflurane_rep3 | strain: Sprague-Dawley age: 18-month old treatment: sevoflurane anesthesia tissue: hippocampus | 8.249067 |
| ID | GSE143895 |
| Title | GPR160 de-orphanization reveals critical roles in neuropathic pain in rodents |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4276356 | dhsc01 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 11.535 |
| GSM4276357 | dhsc03 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 10.876 |
| GSM4276358 | dhsc05 | strain: Sprague Dawley tissue: DHSC treatment: CCI | 13.909 |
| GSM4276359 | dhsc13 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 9.585 |
| GSM4276360 | dhsc15 | strain: Sprague Dawley tissue: DHSC treatment: SHAM | 11.044 |
| ID | GSE157924 |
| Title | Regulation of acupuncture on genes in brain stem |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM4780973 | Rattus_JSSZ(Sham) | tissue: Rattus brainstem of modeling treatment: Sham | 6.9391917945 |
| GSM4780974 | Rattus_JXZ(Hand Acu) | tissue: Rattus brainstem of modeling treatment: Hand Acu | 6.9278213955000005 |
| GSM4780975 | Rattus_MXZ(TBI) | tissue: Rattus brainstem of modeling treatment: TBI | 7.140190756499999 |
| ID | GSE1616 |
| Title | Genomics of preconditioning |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM27484 | APC_a (anesthetic-preconditioning, 1st replicate) | 637.6 | |
| GSM27485 | APC_b (anesthetic-preconditioning, 2nd replicate) | 579.0 | |
| GSM27486 | APC_c (anesthetic-preconditioning, 3rd replicate) | 579.6333333333333 | |
| GSM27487 | APC_d (anesthetic-preconditioning, 4th replicate) | 508.1000000000001 | |
| GSM27488 | APC_e (anesthetic-preconditioning, 5th replicate) | 541.0 | |
| GSM27489 | APC_TRI_a (trigger of anesthetic-preconditioning, 1st replicate) | 692.4333333333334 | |
| GSM27490 | APC_TRI_b (trigger of anesthetic-preconditioning, 2nd replicate) | 611.1999999999999 | |
| GSM27491 | APC_TRI_c (trigger of anesthetic-preconditioning, 3rd replicate) | 485.3666666666666 | |
| GSM27492 | APC_TRI_d (trigger of anesthetic-preconditioning, 4th replicate) | 523.5333333333333 | |
| GSM27493 | APC_TRI_e (trigger of anesthetic-preconditioning, 5th replicate) | 522.9 | |
| GSM27494 | CTL_a (control, 1st replicate) | 861.0666666666666 | |
| GSM27495 | CTL_b (control, 2nd replicate) | 492.8666666666666 | |
| GSM27496 | CTL_c (control, 3rd replicate) | 570.1 | |
| GSM27497 | CTL_d (control, 4th replicate) | 655.1 | |
| GSM27498 | CTL_e (control, 5th replicate) | 744.9333333333334 | |
| GSM27499 | IPC_a (ischemic preconditioning, 1st replicate) | 469.3 | |
| GSM27500 | IPC_b (ischemic preconditioning, 2nd replicate) | 441.46666666666664 | |
| GSM27501 | IPC_c (ischemic preconditioning, 3rd replicate) | 511.70000000000005 | |
| GSM27502 | IPC_d (ischemic preconditioning, 4th replicate) | 602.3333333333334 | |
| GSM27503 | IPC_e (ischemic preconditioning, 5th replicate) | 432.1333333333334 | |
| GSM27504 | IPC_TRI_a (trigger of ischemic preconditioning, 1st replicate) | 777.8000000000001 | |
| GSM27505 | IPC_TRI_b (trigger of ischemic preconditioning, 2nd replicate) | 571.6999999999999 | |
| GSM27506 | IPC_TRI_c (trigger of ischemic preconditioning, 3rd replicate) | 870.0 | |
| GSM27507 | IPC_TRI_d (trigger of ischemic preconditioning, 4th replicate) | 601.5666666666667 | |
| GSM27508 | IPC_TRI_e (trigger of ischemic preconditioning, 5th replicate) | 373.26666666666665 | |
| GSM27509 | ISCH_a (ischemia, 1st replicate) | 308.90000000000003 | |
| GSM27510 | ISCH_b (ischemia, 2nd replicate) | 580.3666666666667 | |
| GSM27511 | ISCH_c (ischemia, 3rd replicate) | 387.43333333333334 | |
| GSM27512 | ISCH_d (ischemia, 4th replicate) | 508.1333333333334 | |
| GSM27513 | ISCH_e (ischemia, 5th replicate) | 473.03333333333336 |
| ID | GSE1779 |
| Title | Effect of Isoflurane and LTM on basolateral amygdala |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM30790 | baseline control 01 | male, 275-300g | 175.25 |
| GSM30791 | baseline control 02 | male, 275-300g | 194.15 |
| GSM30792 | baseline control 03 | male, 275-300g | 216.05 |
| GSM30793 | baseline control 04 | male, 275-300g | 226.9 |
| GSM30794 | baseline control 05 | male, 275-300g | 191.85 |
| GSM30795 | baseline control 06 | male, 275-300g | 196.45 |
| GSM30796 | baseline control 07 | male, 275-300g | 172.1 |
| GSM30797 | baseline control 08 | male, 275-300g | 145.5 |
| GSM30798 | baseline control 09 | male, 275-300g | 233.75 |
| GSM30799 | pain 01 | 226.55 | |
| GSM30800 | pain 02 | 184.75 | |
| GSM30801 | pain 03 | 229.0 | |
| GSM30802 | pain 04 | 224.89999999999998 | |
| GSM30803 | pain 05 | 231.75 | |
| GSM30804 | FC 01 | 216.29999999999998 | |
| GSM30805 | FC 02 | 226.60000000000002 | |
| GSM30806 | FC 03 | 231.3 | |
| GSM30807 | FC 04 | 207.75 | |
| GSM30808 | FC 05 | 201.89999999999998 | |
| GSM30809 | IFC 01 | 215.55 | |
| GSM30810 | IFC 02 | 206.1 | |
| GSM30811 | IFC 03 | 255.79999999999998 | |
| GSM30812 | IFC 04 | 214.85 | |
| GSM30813 | IFC 05 | 192.6 | |
| GSM99800 | isoflurane 01 | male, 275-300g | 217.75 |
| GSM99801 | isoflurane 02 | male, 275-300g | 213.95 |
| GSM99802 | isoflurane 03 | male, 275-300g | 215.9 |
| GSM99803 | isoflurane 04 | male, 275-300g | 238.7 |
| GSM99804 | isoflurane 05 | male, 275-300g | 226.6 |
| ID | GSE190472 |
| Title | Study on VEGF regulation mechanism of acupuncture improving endometrial receptivity in IVF-ET |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5724271 | model 21 | Sex: female tissue: Uterine tissue condition: model | 84.1177 |
| GSM5724272 | model 22 | Sex: female tissue: Uterine tissue condition: model | 59.798649999999995 |
| GSM5724273 | model 23 | Sex: female tissue: Uterine tissue condition: model | 66.5298 |
| GSM5724274 | treatment31 | Sex: female tissue: Uterine tissue condition: treatment | 80.435 |
| GSM5724275 | treatment32 | Sex: female tissue: Uterine tissue condition: treatment | 87.1038 |
| GSM5724276 | treatment33 | Sex: female tissue: Uterine tissue condition: treatment | 69.2743 |
| GSM5724277 | control 41 | Sex: female tissue: Uterine tissue condition: control | 52.1928 |
| GSM5724278 | control 42 | Sex: female tissue: Uterine tissue condition: control | 83.32705 |
| GSM5724279 | control 43 | Sex: female tissue: Uterine tissue condition: control | 61.72875 |
| ID | GSE192399 |
| Title | Gene expression of brain regions activated by sevoflurane and propofol |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5746332 | LHb, Sevoflurane, 60mins | brain region: the lateral habenula (LHb) treatment: Sevoflurane | 9.11811 |
| GSM5746333 | LHb, O2, 60mins | brain region: the lateral habenula (LHb) treatment: O2 | 9.19746 |
| GSM5746334 | MHb, Sevoflurane, 60mins | brain region: the medial habenula (MHb) treatment: Sevoflurane | 9.09945 |
| GSM5746335 | MHb, O2, 60mins | brain region: the medial habenula (MHb) treatment: O2 | 8.98973 |
| GSM5746336 | Sol, Sevoflurane, 60mins | brain region: the solitary nucleus (Sol) treatment: Sevoflurane | 9.77592 |
| GSM5746337 | Sol, O2, 60mins | brain region: the solitary nucleus (Sol) treatment: O2 | 9.65961 |
| GSM5746338 | Mve, Sevoflurane, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Sevoflurane | 8.34659 |
| GSM5746339 | Mve, O2, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: O2 | 8.8042 |
| GSM5746340 | LHb, Propofol, 60mins | brain region: the lateral habenula (LHb) treatment: Propofol | 8.37748 |
| GSM5746341 | LHb, Intralipos, 60mins | brain region: the lateral habenula (LHb) treatment: Intralipos | 7.82599 |
| GSM5746342 | MHb, Propofol, 60mins | brain region: the medial habenula (MHb) treatment: Propofol | 8.449 |
| GSM5746343 | MHb, Intralipos, 60mins | brain region: the medial habenula (MHb) treatment: Intralipos | 8.31476 |
| GSM5746344 | Sol, Propofol, 60mins | brain region: the solitary nucleus (Sol) treatment: Propofol | 9.06171 |
| GSM5746345 | Sol, Intralipos, 60mins | brain region: the solitary nucleus (Sol) treatment: Intralipos | 9.07403 |
| GSM5746346 | MVe, Propofol, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Propofol | 8.09849 |
| GSM5746347 | MVe, Intralipos, 60mins | brain region: the medial vestibular nucleus (MVe) treatment: Intralipos | 8.4396 |
| ID | GSE205202 |
| Title | Hepatic responses of mice and rats to equivalent acetaminophen (APAP) insult [rat] |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM6208507 | Rat_Baseline_0h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 5.611636 |
| GSM6208508 | Rat_Baseline_0h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 5.761488 |
| GSM6208509 | Rat_Baseline_0h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 5.828133 |
| GSM6208510 | Rat_Baseline_0h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 5.713721 |
| GSM6208511 | Rat_Baseline_0h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Untreated hours after treatment: 0 | 5.746783 |
| GSM6208512 | Rat_Vehicle_03h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 5.749463 |
| GSM6208513 | Rat_Vehicle_03h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 5.831399 |
| GSM6208514 | Rat_Vehicle_03h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 5.928876 |
| GSM6208515 | Rat_Vehicle_03h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 5.75173 |
| GSM6208516 | Rat_Vehicle_03h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 3 | 5.706253 |
| GSM6208517 | Rat_Vehicle_06h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 5.739802 |
| GSM6208518 | Rat_Vehicle_06h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 5.816404 |
| GSM6208519 | Rat_Vehicle_06h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 5.47998 |
| GSM6208520 | Rat_Vehicle_06h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 5.642996 |
| GSM6208521 | Rat_Vehicle_06h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 6 | 5.947547 |
| GSM6208522 | Rat_Vehicle_09h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 5.661684 |
| GSM6208523 | Rat_Vehicle_09h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 5.649374 |
| GSM6208524 | Rat_Vehicle_09h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 5.780663 |
| GSM6208525 | Rat_Vehicle_09h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 5.794921 |
| GSM6208526 | Rat_Vehicle_09h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 9 | 5.736462 |
| GSM6208527 | Rat_Vehicle_24h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 5.671189 |
| GSM6208528 | Rat_Vehicle_24h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 5.721585 |
| GSM6208529 | Rat_Vehicle_24h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 5.799743 |
| GSM6208530 | Rat_Vehicle_24h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 5.673865 |
| GSM6208531 | Rat_Vehicle_24h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: Vehicle (1% [w/v] hydroxyethylcellulose, o.g.) hours after treatment: 24 | 5.851188 |
| GSM6208532 | Rat_APAP_03h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 5.585798 |
| GSM6208533 | Rat_APAP_03h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 5.585598 |
| GSM6208534 | Rat_APAP_03h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 5.549432 |
| GSM6208535 | Rat_APAP_03h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 5.673345 |
| GSM6208536 | Rat_APAP_03h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 3 | 5.719354 |
| GSM6208537 | Rat_APAP_06h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 5.611991 |
| GSM6208538 | Rat_APAP_06h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 5.730502 |
| GSM6208539 | Rat_APAP_06h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 5.852005 |
| GSM6208540 | Rat_APAP_06h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 5.613349 |
| GSM6208541 | Rat_APAP_06h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 6 | 5.760901 |
| GSM6208542 | Rat_APAP_09h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 5.663246 |
| GSM6208543 | Rat_APAP_09h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 5.63536 |
| GSM6208544 | Rat_APAP_09h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 5.624682 |
| GSM6208545 | Rat_APAP_09h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 5.618039 |
| GSM6208546 | Rat_APAP_09h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 9 | 5.583694 |
| GSM6208547 | Rat_APAP_24h_1 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 5.867405 |
| GSM6208548 | Rat_APAP_24h_2 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 5.850624 |
| GSM6208549 | Rat_APAP_24h_3 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 5.561916 |
| GSM6208550 | Rat_APAP_24h_4 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 5.559529 |
| GSM6208551 | Rat_APAP_24h_5 | tissue: liver strain: Sprague-Dawley Sex: male treatment: 1000 mg/kg acetamnophen (o.g.) hours after treatment: 24 | 5.801879 |
| ID | GSE232804 |
| Title | EGR3 regulates opioid-related nociception and motivation in male rats |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7383519 | ww01_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 701.0 |
| GSM7383520 | ww02_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 852.0 |
| GSM7383521 | ww03_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 1050.0 |
| GSM7383522 | ww05_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 1020.0 |
| GSM7383523 | ww06_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 1000.0 |
| GSM7383524 | ww07_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 917.0 |
| GSM7383525 | ww08_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Salin | 944.0 |
| GSM7383526 | ww10_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 872.0 |
| GSM7383527 | ww12_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 970.0 |
| GSM7383528 | ww13_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 1148.0 |
| GSM7383529 | ww14_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 680.0 |
| GSM7383530 | ww15_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 840.0 |
| GSM7383531 | ww16_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 1086.0 |
| GSM7383532 | ww17_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 1341.0 |
| GSM7383533 | ww18_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 982.0 |
| GSM7383534 | ww20_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 856.0 |
| GSM7383535 | ww21_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 701.0 |
| GSM7383536 | ww22_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 782.0 |
| GSM7383537 | ww23_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 935.0 |
| GSM7383538 | ww24_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 939.0 |
| GSM7383539 | ww26_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 760.0 |
| GSM7383540 | ww27_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 804.0 |
| GSM7383541 | ww28_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 821.0 |
| GSM7383542 | ww30_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 720.0 |
| GSM7383543 | ww31_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 755.0 |
| GSM7383544 | ww32_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 878.0 |
| GSM7383545 | ww34_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 1247.0 |
| GSM7383546 | ww35_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 869.0 |
| GSM7383547 | ww36_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 931.0 |
| GSM7383548 | ww37_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 895.0 |
| GSM7383549 | ww38_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 1181.0 |
| GSM7383550 | www09_Saline_Saline | tissue: Brain / mPFC pain: Saline drug: Saline | 949.0 |
| GSM7383551 | www19_Saline_OXY | tissue: Brain / mPFC pain: Saline drug: OXY | 1096.0 |
| GSM7383552 | www29_CFA_Saline | tissue: Brain / mPFC pain: CFA drug: Saline | 950.0 |
| GSM7383553 | www33_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 924.0 |
| GSM7383554 | www39_CFA_OXY | tissue: Brain / mPFC pain: CFA drug: OXY | 927.0 |
| ID | GSE244436 |
| Title | Similarity and dissimilarity in alteration of gene expression profile associated with inhalational anesthesia between sevoflurane and desflurane |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM7816143 | Liver, Control for SevoAnes | tissue: liver genotype: wild type treatment: Control for SevoAnes | 0.204712 |
| GSM7816144 | Liver, Anesthetized with sevoflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with sevoflurane for 6 h | 0.264608 |
| GSM7816145 | Liver, Control for DesAnes | tissue: liver genotype: wild type treatment: Control for DesAnes | 0.175079 |
| GSM7816146 | Liver, Anesthetized with desflurane for 6 h | tissue: liver genotype: wild type treatment: Anesthetized with desflurane for 6 h | 0.328312 |
| ID | GSE2982 |
| Title | Effect of inhaled anesthetic to cultured cortical neurons |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM61779 | Cell Culture Exposure (control1) | Cy3 label;Cy5; | -0.0213 |
| GSM61796 | Cell Culture Exposure (control2) | Cy3; Cy5 | 0.066 |
| GSM61797 | Cell Culture Exposure (control3) | Cy3; Cy5 | 0.123 |
| GSM61798 | Cell Culture Exposure (1MAC Halo1) | Cy3; Cy5 | -0.128 |
| GSM61799 | Cell Culture Exposure (1MAC Halo2) | Cy3; Cy5 | 0.0227 |
| GSM61800 | Cell Culture Exposure (1MAC Halo3) | Cy3; Cy5 | 0.067 |
| GSM61801 | Cell Culture Exposure (3MAC Halo1) | Cy3; Cy5 | 0.124 |
| GSM61802 | Cell Culture Exposure (3MAC Halo2) | Cy3; Cy5 | 0.0738 |
| GSM61803 | Cell Culture Exposure (3MAC Halo3) | Cy3; Cy5 | 0.134 |
| GSM61804 | Cell Culture Exposure (3MAC ISO1) | Cy3; Cy5 | 0.182 |
| GSM61805 | Cell Culture Exposure (3MAC ISO2) | Cy3; Cy5 | 0.0479 |
| GSM61806 | Cell Culture Exposure (3MAC ISO3) | Cy3; Cy5 | 0.112 |
| ID | GSE359 |
| Title | Isoflurane Single Exposures |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5120 | Isoflurane single exposure control-1 | 47.46666666666667 | |
| GSM5121 | Isoflurane single exposure control-2 | 48.4 | |
| GSM5122 | Isoflurane single exposure control-3 | 34.53333333333334 | |
| GSM5124 | Isoflurane single exposure 1 hr-1 | 64.0 | |
| GSM5126 | Isoflurane single exposure 1 hr-2 | 26.96666666666667 | |
| GSM5127 | Isoflurane single exposure 2 hr-1 | 48.13333333333333 | |
| GSM5130 | Isoflurane single exposure 2 hr-2 | 32.03333333333333 | |
| GSM5131 | Isoflurane single exposure 2 hr-3 | 41.43333333333333 |
| ID | GSE48025 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch1) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.9358162500000002 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.872799524 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 3.968396282 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 3.8948189534999997 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.775385258 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.949228038 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 4.099828068 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 3.7179808850000002 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.8108404819999997 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.8217477210000004 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 4.0356210265 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 4.054469065999999 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 3.9155225955 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 4.175150632499999 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.686078434 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.9100419485 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 3.957151108 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 3.9971115470000003 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 3.8064849339999998 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 3.912728691 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 4.0570664005 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 4.1052739764999995 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 4.0085260179999995 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 4.084719751 |
| ID | GSE53897 |
| Title | Genome-wide analysis of dorsal root ganglion (DRG) gene expression after morphine or oxycodone treatment |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1303240 | DRG RVM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.609897 |
| GSM1303241 | DRG RVM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.555872 |
| GSM1303242 | DRG RVM3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.687053 |
| GSM1303243 | DRG RVM7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.485931 |
| GSM1303244 | DRG RVOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.489428 |
| GSM1303245 | DRG RVOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.766421 |
| GSM1303246 | DRG RVOx5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.507206 |
| GSM1303247 | DRG RVOx7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.690503 |
| GSM1303248 | DRG RVS4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.752002 |
| GSM1303249 | DRG RVS5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.599701 |
| GSM1303250 | DRG RVS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.618345 |
| GSM1303251 | DRG RVS7 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.646413 |
| GSM1303252 | DRG RSM1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.692245 |
| GSM1303253 | DRG RSM2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.950446 |
| GSM1303254 | DRG RSM4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.471729 |
| GSM1303255 | DRG RSM5 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.735858 |
| GSM1303256 | DRG RSOx1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.505455 |
| GSM1303257 | DRG RSOx2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.862755 |
| GSM1303258 | DRG RSOx3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.666331 |
| GSM1303259 | DRG RSOx4 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.972358 |
| GSM1303260 | DRG RSS1 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.703248 |
| GSM1303261 | DRG RSS2 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 8.072638 |
| GSM1303262 | DRG RSS3 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.673196 |
| GSM1303263 | DRG RSS6 | strain: sprague-dawley age: 3 months tissue: dorsal root ganglion | 7.798043 |
| ID | GSE55573 |
| Title | Using DNA microarray to screen intracellular signal pathways of hypoglycemic activity by electroacupuncture of Zusanli (ST36) acupoints in streptozotocin-induced rats with diabetes |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1339443 | Mock skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 122.7269 |
| GSM1339444 | EA (electroacupuncture) skeletal muscle | strain: Wistar age: 8-10 week-old gender: Male | 118.0724 |
| ID | GSE58456 |
| Title | Affymetrix Chip Data of the Transcriptome of the Rheumatoid Arthritis Rat Model Treated with Acupuncture (Affymetrix, mRNA, batch 2) |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 74.322911 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 18.4579698595 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 45.761073975 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 31.863175055 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 9.810663429 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 20.284307369 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 34.978863939 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 26.740206825 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 21.04805487 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 41.082843185 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 43.450394765 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 44.23980984 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 74.57670874 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 26.089111737499998 |
| ID | GSE58460 |
| Title | Rheumatoid Arthritis Rat Model Treated with Acupuncture |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM1165929 | RAT_NORA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.9358162500000002 |
| GSM1165930 | RAT_NORA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats before therapy | 3.872799524 |
| GSM1165931 | RAT_RA_T0_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 3.968396282 |
| GSM1165932 | RAT_RA_T0_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats before therapy | 3.8948189534999997 |
| GSM1165933 | RAT_NORA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.775385258 |
| GSM1165934 | RAT_NORA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 1 hour after therapy | 3.949228038 |
| GSM1165935 | RAT_AP_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 4.099828068 |
| GSM1165936 | RAT_AP_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour acupuncture therapy | 3.7179808850000002 |
| GSM1165937 | RAT_MTX_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.8108404819999997 |
| GSM1165938 | RAT_MTX_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour MTX therapy | 3.8217477210000004 |
| GSM1165939 | RAT_ANE_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 4.0356210265 |
| GSM1165940 | RAT_ANE_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour ANE therapy | 4.054469065999999 |
| GSM1165941 | RAT_PLA_1h_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 3.9155225955 |
| GSM1165942 | RAT_PLA_1h_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 1 hour placebo therapy | 4.175150632499999 |
| GSM1165943 | RAT_NORA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.686078434 |
| GSM1165944 | RAT_NORA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: healthy rats at 34 days after therapy | 3.9100419485 |
| GSM1165945 | RAT_AP_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 3.957151108 |
| GSM1165946 | RAT_AP_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days acupuncture therapy | 3.9971115470000003 |
| GSM1165947 | RAT_MTX_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 3.8064849339999998 |
| GSM1165948 | RAT_MTX_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days MTX therapy | 3.912728691 |
| GSM1165949 | RAT_ANE_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 4.0570664005 |
| GSM1165950 | RAT_ANE_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days ANE therapy | 4.1052739764999995 |
| GSM1165951 | RAT_PLA_34d_1 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 4.0085260179999995 |
| GSM1165952 | RAT_PLA_34d_2 | gender: Female tissue: RAT Peripheral blood mononuclear cells strain: Wistar rat subject group: RA rats after 34 days placebo therapy | 4.084719751 |
| GSM1412003 | RAT_NORA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412004 | RAT_NORA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412005 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412006 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412007 | RAT_NORA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412008 | RAT_NORA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412009 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412010 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412011 | RAT_MTX_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412012 | RAT_MTX_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412013 | RAT_ANE_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412014 | RAT_ANE_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412015 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412016 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412017 | RAT_NORA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412018 | RAT_NORA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412019 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412020 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412021 | RAT_MTX_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412022 | RAT_MTX_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412023 | RAT_ANE_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412024 | RAT_ANE_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412025 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412026 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Peripheral blood mononuclear cells | |
| GSM1412027 | RAT_RA_T0_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412028 | RAT_RA_T0_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412029 | RAT_AP_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412030 | RAT_AP_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412031 | RAT_PLA_1h_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412032 | RAT_PLA_1h_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412033 | RAT_AP_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412034 | RAT_AP_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412035 | RAT_PLA_34d_1 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1412036 | RAT_PLA_34d_2 | strain: Wistar gender: Female tissue: RAT Sub-epidermidis muscle tissue | |
| GSM1693996 | Peripheral blood mononuclear cells from NORA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therap | 74.322911 |
| GSM1693997 | Peripheral blood mononuclear cells from NORA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 18.4579698595 |
| GSM1693998 | Peripheral blood mononuclear cells from NORA before therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats before therapy | 45.761073975 |
| GSM1693999 | Peripheral blood mononuclear cells from RA before therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 31.863175055 |
| GSM1694000 | Peripheral blood mononuclear cells from RA before therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats before therapy | 9.810663429 |
| GSM1694001 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 20.284307369 |
| GSM1694002 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therap | 34.978863939 |
| GSM1694003 | Peripheral blood mononuclear cells from HAP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: healthy rats after 34 days acupuncture therapy | 26.740206825 |
| GSM1694004 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 21.04805487 |
| GSM1694005 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 41.082843185 |
| GSM1694006 | Peripheral blood mononuclear cells from AP after 34 days acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days acupuncture therapy | 43.450394765 |
| GSM1694007 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 1 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 44.23980984 |
| GSM1694008 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 2 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 74.57670874 |
| GSM1694009 | Peripheral blood mononuclear cells from MTXAP after 34 days MTX&acupuncture therapy, replicate 3 | strain/background: Wistar gender: female cell type: peripheral blood mononuclear cells subject group: rheumatoid arthritis rats after 34 days methotrexate & acupuncture therapy | 26.089111737499998 |
| ID | GSE752 |
| Title | Halothane/Isoflurane Repetitive Exposures |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM5082 | Control 1 | 51.26666666666667 | |
| GSM5084 | Control 2 | 55.06666666666666 | |
| GSM5085 | Control 3 | 46.333333333333336 | |
| GSM5086 | Control 4 | 67.76666666666667 | |
| GSM5087 | Control 5 | 57.03333333333333 | |
| GSM5090 | Control 6 | 72.46666666666665 | |
| GSM5105 | Control 7 | 66.73333333333333 | |
| GSM5106 | Control 8 | 61.76666666666667 | |
| GSM5107 | Control 9 | 51.53333333333334 | |
| GSM5108 | Halothane 10 exposure-1 | 56.199999999999996 | |
| GSM5109 | Halothane 10 exposures-2 | 51.599999999999994 | |
| GSM5110 | Halothane 10 exposures-3 | 52.43333333333334 | |
| GSM5111 | Halothane 5 exposures-1 | 61.46666666666667 | |
| GSM5112 | Halothane 5 exposures-2 | 53.9 | |
| GSM5113 | Halothane 5 exposures-3 | 47.300000000000004 | |
| GSM5114 | Isoflurane 10 exposures-1 | 46.599999999999994 | |
| GSM5115 | Isoflurane 10 exposures-2 | 68.56666666666668 | |
| GSM5116 | Isoflurane 10 exposures-3 | 46.6 | |
| GSM5117 | Isoflurane 5 exposures-1 | 53.96666666666667 | |
| GSM5118 | Isoflurane 5 exposures-2 | 61.199999999999996 | |
| GSM5119 | Isoflurane 5 exposures-3 | 48.76666666666667 | |
| GSM11379 | Control 10 | 50.76666666666666 | |
| GSM11380 | Control 11 | 53.699999999999996 | |
| GSM11381 | Control 12 | 56.46666666666667 |
| ID | GSE8911 |
| Title | Skeletal muscle after fine needle stimulation |
| Organism | Rattus norvegicus |
| GSM | Sample info | Characteristics | Value |
|---|---|---|---|
| GSM225891 | Skeletal muscle sample from fine needle-stimulated hindlimb | Strain: Lewis, Gender: Male, Body Weight: 275g, Tissue: Skeletal muscle sample from fine nnedle-stimulated hindlimb | 9.817625 |
| GSM225892 | Skeletal muscle sample from control hindlimb | Strain: Lewis, Gender: Male, Body weight: 275g, Tissue: skeletal muscle sample from non fine needle-stimulated hindlimb | 8.597185 |
